Highly Potent Drugs

May 16, 2018
By Pharmaceutical Technology Editors
Cambrex Corporation has announced facility, equipment, and instrument upgrades at its High Point, NC facility and updated progress on expansions in Cedar City, IA.
May 15, 2018
Pharmaceutical Technology
Choosing the right contamination control platform requires considerable research into what a product needs for an effective process design.
May 10, 2018
By Pharmaceutical Technology Editors
The technology, known as Verifi, is available with the ChargePoint’s range of valves that ensure safe and contamination-free handling of API and other formulation ingredients.
Feb 13, 2018
By Pharmaceutical Technology Editors
Unlike current approaches where bioconjugation is typically done following the manufacture of the monoclonal antibody and the cytotoxic drug, the new method begins with the antibody supernatants and eliminates the need for extensive chromatographic purification.
Feb 01, 2018
By Pharmaceutical Technology Editors
Cambrex invests in development and laboratory facilities and adds staff.
Jan 25, 2018
By Pharmaceutical Technology Editors
Hovione has installed a new MG2 Tekna Precision Capsule filler at its Portugal site.
Oct 02, 2017
Pharmaceutical Technology
CDMOs have established strategies for handling new chemical entities with unknown biological activity.
Aug 10, 2017
By Pharmaceutical Technology Editors
Cambrex is investing $24 Million in new, highly potent API manufacturing capacity at its Charles City, Iowa site.
Aug 03, 2017
By Pharmaceutical Technology Editors
CordenPharma is investing €10 Million in a new line at its Plankstadt, Germany site.
Jul 19, 2017
By Pharmaceutical Technology Editors
ChargePoint Technology is expanding its US presence by opening a new office in San Francisco.
native1_300x100
lorem ipsum